Transcription inhibition: A potential strategy for cancer therapeutics
- 1 November 2005
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (16) , 2569-2576
- https://doi.org/10.1016/j.ejca.2005.08.012
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- The role of apoptosis in cancer development and treatment responseNature Reviews Cancer, 2005
- Efficient NES-dependent protein nuclear export requires ongoing synthesis and export of mRNAsExperimental Cell Research, 2004
- DNA Damage Induces p53-dependent BRCA1 Nuclear ExportJournal of Biological Chemistry, 2004
- Nuclear accumulation of p53 following inhibition of transcription is not due to diminished levels of MDM2Oncogene, 2004
- Nuclear transport and cancer: from mechanism to interventionNature Reviews Cancer, 2004
- Oxygen-Dependent Ubiquitination and Degradation of Hypoxia-Inducible Factor Requires Nuclear-Cytoplasmic Trafficking of the von Hippel-Lindau Tumor Suppressor ProteinMolecular and Cellular Biology, 2002
- Mechanism of regulation of the hypoxia-inducible factor-1alpha by the von Hippel-Lindau tumor suppressor proteinThe EMBO Journal, 2000
- The Hallmarks of CancerCell, 2000
- Transport Between the Cell Nucleus and the CytoplasmAnnual Review of Cell and Developmental Biology, 1999
- Signal transduction through NF-κBImmunology Today, 1998